AbbVie Inc.ABBVNYSE
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+10.7%
5Y CAGR+11.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+10.7%/yr
vs +3.3%/yr prior
5Y CAGR
+11.4%/yr
Consistent
Acceleration
+7.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
5 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 6.69 | +19.9% |
| 2024 | 5.58 | +10.6% |
| 2023 | 5.04 | +2.3% |
| 2022 | 4.93 | +15.6% |
| 2021 | 4.26 | +9.4% |
| 2020 | 3.90 | -1.1% |
| 2019 | 3.94 | -9.1% |
| 2018 | 4.34 | -20.7% |
| 2017 | 5.47 | +38.1% |
| 2016 | 3.96 | - |